Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Quazim Alayo
Arming an Oncolytic Herpes Simplex Virus Type 1 With a Single Chain Fragment Variable Antibody Against PD-1 for Experimental Glioblastoma Therapy.
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 With Integrin Β1 Blocking Antibody OS2966
Molecular Cancer Therapeutics
Cancer Research
Oncology
Antiviral Effects of Blackberry Extract Against Herpes Simplex Virus Type 1
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
Protective Antibody Therapy Is Associated With Reduced Chemokine Transcripts in Herpes Simplex Virus Type 1 Corneal Infection.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy
Oncolytic Virotherapy
A Humanized Single-Chain Variable Fragment Antibody Against Beta3 Integrin inEscherichia Coli
Hybridoma
Experimental Herpes Simplex Virus Type 1 Encephalitis: Treatment With 5-Trifluoromethyl-2'-Deoxyuridine
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Development of a New Fusion-Enhanced Oncolytic Immunotherapy Platform Based on Herpes Simplex Virus Type 1
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Functional Recombinant Single‑chain Variable Fragment Antibody Against Agkistrodon Acutus Venom
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Ribonucleotide Reductase of Herpes Simplex Virus Type 2 Resembles That of Herpes Simplex Virus Type 1.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology